logo-loader
viewAdvanced Oncotherapy PLC

Advanced Oncotherapy reassures on Harley Street plans

Advanced Oncotherapy PLC moved to reassure investors that the withdrawal of a planning application in January will not impact the firm's development of a proton beam therapy facility.

Pictured Harley Street sign - the prestigious address for private healthcare will be host to Advanced Oncotherapy’s proton beam therapies
Harley Street - the prestigious address for private healthcare will be host to Advanced Oncotherapy’s proton beam therapies

Advanced Oncotherapy PLC (LON:AVO) moved to reassure investors that the withdrawal of a planning application in January will not impact the firm's development of a proton beam therapy facility.

Howard de Walden Estates' withdrawn application at 141-143 Harley Street, a road in London synonymous with all things medical, was for 'use swap' purposes.

It did not involve any works to the building which are part of creating the facility, the AIM firm said.

Indeed, the available space for the centre has increased by around 50% allowing for an additional treatment room and additional imaging facilities, it added.

Howard de Walden Estates, which are bearing the total cost of the re-development,  are satisfied that progress for the site remains on track.

Advanced Oncotherapy shares lost 1.85% to stand at 6.625p.

Quick facts: Advanced Oncotherapy PLC

Price: 38 GBX

LSE:AVO
Market: LSE
Market Cap: £92.88 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Advanced Oncotherapy PLC named herein, including the promotion by the Company of Advanced Oncotherapy PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: VR Education's ENGAGE platform to be included in new 5G VR...

Headlines from the Proactive UK newsroom. VR Education’s (LON:VRE) Engage platform has been chosen as an embedded title in a new 5G virtual reality headset being developed by a consortium of Deutsche Telekom, Qualcomm and XRSPACE. The new headset is due to launch in...

on 4/12/19

2 min read